TNF and rheumatoid arthritis: Similar results have been reported for tumor necrosis factor-α (TNF-α) which promoted platelet aggregation and activation [85], while TNF-α inhibitors abrogated platelet activation, platelet-leukocyte interactions, and tissue factor expression in patients with rheumatoid arthritis [86].